ICD-Therapie in Deutschland: Über- oder Unterversorgung?

Zusammenfassung

Die ICD-Therapie hat sich durch eine Vielzahl randomisierter Studien in den vergangenen Jahren zu einem etablierten Bestandteil in der Behandlung von Herzerkrankungen und der Prophylaxe des plötzlichen Herztods entwickelt. Im internationalen Vergleich werden in Deutschland überproportional viele ICD implantiert, ohne hierfür schlüssige Gründe zu kennen. Möglicherweise liegt für spezielle Patientengruppen eine Überversorgung mit ICD vor. Eine individuelle Beurteilung in Anlehnung an Leitlinien und entsprechende Beratung von Patienten können hier wertvoll sein.

Abstract

Numerous randomized trials elucidated ICD-Therapy as an essential part of preventing sudden cardiac death. Compared to other countries there are over disproportionately more ICD implantations in Germany. There seems to be an over-supply in ICD implantations in certain groups of patients. Individual assessment according to current guidelines and guidance of patients may be helpful.

Schlüsselwörter

implantierbarer Kardioverter-Defibrillator - plötzlicher Herztod - Versorgungslage

Key words

implantable cardioverter-defibrillator - sudden cardiac death - supply situation

• Literatur

• 1 Mirowski M, Reid PR, Mower MM et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980; 303: 322-324
• 2 Connolly SJ, Hallstrom AP, Cappato R et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 2000; 21: 2071-2078
• 3 Moss AJ, Zareba W, Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883
• 4 Bardy GH, Lee KL, Mark DB et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237
• 5 Priori SG, Blomstrom-Lundqvist C, Mazzanti A et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015; 36: 2793-2867
• 6 Markewitz A. Jahresbericht 2013 des Deutschen Herzschrittmacher- und Defibrillatorregisters, Teil 2 – Implantierbare Cardioverter-Defibrillatoren. Fachgruppe Herzschrittmacher und AQUA – Institut für angewandte Qualitätsförderung und Forschung im Gesundheitswesen GmbH. Herzschrittmacherther Elektrophysiol 2015; 26: 399-423
• 7 Raatikainen MJ, Arnar DO, Zeppenfeld K et al. Current trends in the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology member countries: 2015 report from the European Heart Rhythm Association. Europace 2015; 17 (Suppl. 04) iv1-iv72
• 8 Solomon SD, Zelenkofske S, McMurray JJV et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 2005; 352: 2581-2588
• 9 Wasmer K, Köbe J, Andresen D et al. Comparing outcome of patients with coronary artery disease and dilated cardiomyopathy in ICD and CRT recipients: data from the German DEVICE-registry. Clin Res Cardiol 2013; 102: 513-521
• 10 Sedláček K, Ruwald AC, Kutyifa V et al. The effect of ICD programming on inappropriate and appropriate ICD Therapies in ischemic and nonischemic cardiomyopathy: the MADIT-RIT trial. J Cardiovasc Electrophysiol 2015; 26: 424-433
• 11 Healey JS, Hallstrom AP, Kuck KH et al. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Eur Heart J 2007; 28: 1746-1749
• 12 Santangeli P, Di Biase L, Russo Dello A et al. Meta-analysis: age and effectiveness of prophylactic implantable cardioverter-defibrillators. Ann Intern Med 2010; 153: 592-599
• 13 Segall L, Nistor I, Covic A. Heart failure in patients with chronic kidney disease: a systematic integrative review. Biomed Res Int 2014; 2014: 937398
• 14 Pun PH, Al-Khatib SM, Han JY et al. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials. Am J Kidney Dis 2014; 64: 32-39
• 15 Pun PH, Hellkamp AS, Sanders GD et al. Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study. Nephrol Dial Transplant 2015; 30: 829-835
• 16 Morden NE, Colla CH, Sequist TD et al. Choosing wisely—the politics and economics of labeling low-value services. N Engl J Med 2014; 370: 589-592